The FDA has awarded the designation following a review of initial safety and efficacy data from two Phase I/II clinical trials.

UK liquid biopsy company, Angle, has agreed a supplier agreement with AstraZeneca to develop a Parsotix-based Androgen Receptor (AR) assay for use in prostate cancer studies.

Amgen ’s total revenues grew in Q1 2024 to $7.4bn, displaying a 22% increase from earnings reported in the first quarter of last year.

The NHS in the UK has announced plans to offer Pfizer's Voxelotor (Oxbryta), a new treatment option for sickle cell disease.

Under the terms of the deal, Mariana will receive $1bn and up to $750m in additional milestone payments from Novartis.

Emergent also said it will shut down two of its US-based complexes – a drug substance manufacturing facility in Baltimore and ...

The investment aims to expedite the development of the company’s precision oncology pipeline. Credit: Alex_Traksel / ...

AstraZeneca has maintained that while the vaccine may, in “very rare” cases, cause TTS, the casual mechanism for this effect ...

Lexicon’s Zynquista (sotagliflozin) is an oral dual inhibitor of the sodium-dependent glucose co-transporter types 1 and 2 ...

Janssen-Cilag has sought expanded European Medicines Agency (EMA) approval for TREMFYA to treat active ulcerative colitis and ...

Pfizer’s reported net income stood at $3.11bn in Q1 2024, marking a decrease of 44% from $5.54bn posted in the same period of ...

Bayer and Evotec have expanded collaboration to focus on the development of precision treatments for cardiovascular diseases ...